Q32 Bio FCF par action

Que fait Q32 Bio ? Q32 Bio Inc, trading under the ticker QTTB with ISIN US7469641051, is a biotechnology company based in Bedford, United States. The company operates within the Health Care sector, specifically in the Biotechnology industry. Q32 Bio Inc has 24 employees and completed its initial public offering (IPO) on March 28, 2018. The company's website is https://www.homologymedicines.com/. While the source description provided references Homology Medicines, Inc. and includes details such as a 205-employee count, an IPO date of March 28, 2018, and a lead product candidate named HMI-102 for phenylketonuria (PKU), these details are inconsistent with the provided company profile. The factual information for Q32 Bio Inc includes its location, sector, employee count, IPO date, and website. The company is engaged in developing treatments for rare diseases at the genetic level, focusing on monogenic diseases affecting various tissues including the liver, central nervous system, bone marrow, lung, and eye. The company utilizes a platform of adeno-associated virus vectors for gene editing and therapy approaches. However, specific details about product names, additional employee figures, or other operational specifics beyond the provided data are not included in the factual profile. Q32 Bio est l'une des entreprises les plus populaires sur Eulerpool.